This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Academy of Military Medical Sciences, Chengdu Aupone Pharmaceutical Co., Ltd, Sichuan University. Active years: 2026.
Company Filing History:
1 out of 14 
1 out of 1 
1 out of 260 Years Active: 2026
Title: Fanglin Xue: Innovator in C-Nucleoside Synthesis
Introduction
Fanglin Xue is a notable inventor based in Chengdu, China. He has made significant contributions to the field of chemistry, particularly in the synthesis of C-nucleoside compounds. His innovative methods have implications for large-scale pharmaceutical production.
Latest Patents
Fanglin Xue holds a patent for a method for synthesizing a C-nucleoside compound. This method, represented by Formula (III) or its salt, boasts a high reaction yield and is simple to operate. It utilizes a single metal reagent and maintains stable reaction temperature conditions. The process does not require frequent changes to the reaction system, making it suitable for scale-up synthesis and large-scale production of Remdesivir, all while keeping costs low.
Career Highlights
Fanglin Xue has worked at prestigious institutions such as Sichuan University and the Academy of Military Medical Sciences. His experience in these organizations has allowed him to develop and refine his innovative methods in chemical synthesis.
Collaborations
Fanglin has collaborated with notable colleagues, including Yong Qin and Wu Zhong. Their combined expertise has contributed to advancements in their respective fields.
Conclusion
Fanglin Xue's work in synthesizing C-nucleoside compounds represents a significant advancement in pharmaceutical chemistry. His innovative methods and collaborations highlight his impact on the industry.